These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 17531344)

  • 1. Inhibition of HCV RNA-dependent RNA polymerase activity by aqueous extract from Fructus Ligustri Lucidi.
    Kong L; Li S; Han X; Xiang Z; Fang X; Li B; Wang W; Zhong H; Gao J; Ye L
    Virus Res; 2007 Sep; 128(1-2):9-17. PubMed ID: 17531344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A cell-based assay for RNA synthesis by the HCV polymerase reveals new insights on mechanism of polymerase inhibitors and modulation by NS5A.
    Ranjith-Kumar CT; Wen Y; Baxter N; Bhardwaj K; Cheng Kao C
    PLoS One; 2011; 6(7):e22575. PubMed ID: 21799903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interference of HCV replication by cell penetrable human monoclonal scFv specific to NS5B polymerase.
    Thueng-in K; Thanongsaksrikul J; Jittavisutthikul S; Seesuay W; Chulanetra M; Sakolvaree Y; Srimanote P; Chaicumpa W
    MAbs; 2014; 6(5):1327-39. PubMed ID: 25517317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oleanolic acid and ursolic acid: novel hepatitis C virus antivirals that inhibit NS5B activity.
    Kong L; Li S; Liao Q; Zhang Y; Sun R; Zhu X; Zhang Q; Wang J; Wu X; Fang X; Zhu Y
    Antiviral Res; 2013 Apr; 98(1):44-53. PubMed ID: 23422646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of hepatitis C virus replication by herbal extract: Phyllanthus amarus as potent natural source.
    Ravikumar YS; Ray U; Nandhitha M; Perween A; Raja Naika H; Khanna N; Das S
    Virus Res; 2011 Jun; 158(1-2):89-97. PubMed ID: 21440018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-nucleoside inhibitors of the hepatitis C virus NS5B RNA-dependant RNA polymerase: 2-aryl-3-heteroaryl-1,3-thiazolidin-4-one derivatives.
    Rawal RK; Katti SB; Kaushik-Basu N; Arora P; Pan Z
    Bioorg Med Chem Lett; 2008 Dec; 18(23):6110-4. PubMed ID: 18947995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Fructus Ligustri Lucidi on osteoblastic like cell-line MC3T3-E1.
    Li Q; Fan YS; Gao ZQ; Fan K; Liu ZJ
    J Ethnopharmacol; 2015 Jul; 170():88-95. PubMed ID: 25978950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and preliminary optimization of indole-N-acetamide inhibitors of hepatitis C virus NS5B polymerase.
    Harper S; Pacini B; Avolio S; Di Filippo M; Migliaccio G; Laufer R; De Francesco R; Rowley M; Narjes F
    J Med Chem; 2005 Mar; 48(5):1314-7. PubMed ID: 15743173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic potential of Taraxacum officinale against HCV NS5B polymerase: In-vitro and In silico study.
    Rehman S; Ijaz B; Fatima N; Muhammad SA; Riazuddin S
    Biomed Pharmacother; 2016 Oct; 83():881-891. PubMed ID: 27513212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current perspective of HCV NS5B inhibitors: a review.
    Patil VM; Gupta SP; Samanta S; Masand N
    Curr Med Chem; 2011; 18(36):5564-97. PubMed ID: 22172066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The novel nucleoside analog R1479 (4'-azidocytidine) is a potent inhibitor of NS5B-dependent RNA synthesis and hepatitis C virus replication in cell culture.
    Klumpp K; Lévêque V; Le Pogam S; Ma H; Jiang WR; Kang H; Granycome C; Singer M; Laxton C; Hang JQ; Sarma K; Smith DB; Heindl D; Hobbs CJ; Merrett JH; Symons J; Cammack N; Martin JA; Devos R; Nájera I
    J Biol Chem; 2006 Feb; 281(7):3793-9. PubMed ID: 16316989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in discovery and development of promising therapeutics against hepatitis C virus NS5B RNA-dependent RNA polymerase.
    Wu JZ; Yao N; Walker M; Hong Z
    Mini Rev Med Chem; 2005 Dec; 5(12):1103-12. PubMed ID: 16375756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of aurintricarboxylic acid as a potent hepatitis C virus replicase inhibitor.
    Chen Y; Bopda-Waffo A; Basu A; Krishnan R; Silberstein E; Taylor DR; Talele TT; Arora P; Kaushik-Basu N
    Antivir Chem Chemother; 2009 Sep; 20(1):19-36. PubMed ID: 19794229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific inhibitors of HCV polymerase identified using an NS5B with lower affinity for template/primer substrate.
    McKercher G; Beaulieu PL; Lamarre D; LaPlante S; Lefebvre S; Pellerin C; Thauvette L; Kukolj G
    Nucleic Acids Res; 2004; 32(2):422-31. PubMed ID: 14739234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Further SAR studies on novel small molecule inhibitors of the hepatitis C (HCV) NS5B polymerase.
    Reddy TJ; Chan L; Turcotte N; Proulx M; Pereira OZ; Das SK; Siddiqui A; Wang W; Poisson C; Yannopoulos CG; Bilimoria D; L'Heureux L; Alaoui HM; Nguyen-Ba N
    Bioorg Med Chem Lett; 2003 Oct; 13(19):3341-4. PubMed ID: 12951122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional characterization of fingers subdomain-specific monoclonal antibodies inhibiting the hepatitis C virus RNA-dependent RNA polymerase.
    Nikonov A; Juronen E; Ustav M
    J Biol Chem; 2008 Aug; 283(35):24089-102. PubMed ID: 18574240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of inhibition for BMS-791325, a novel non-nucleoside inhibitor of hepatitis C virus NS5B polymerase.
    Rigat KL; Lu H; Wang YK; Argyrou A; Fanslau C; Beno B; Wang Y; Marcinkeviciene J; Ding M; Gentles RG; Gao M; Abell LM; Roberts SB
    J Biol Chem; 2014 Nov; 289(48):33456-68. PubMed ID: 25301950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PSI-7851, a pronucleotide of beta-D-2'-deoxy-2'-fluoro-2'-C-methyluridine monophosphate, is a potent and pan-genotype inhibitor of hepatitis C virus replication.
    Lam AM; Murakami E; Espiritu C; Steuer HM; Niu C; Keilman M; Bao H; Zennou V; Bourne N; Julander JG; Morrey JD; Smee DF; Frick DN; Heck JA; Wang P; Nagarathnam D; Ross BS; Sofia MJ; Otto MJ; Furman PA
    Antimicrob Agents Chemother; 2010 Aug; 54(8):3187-96. PubMed ID: 20516278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for Internal Initiation of RNA Synthesis by the Hepatitis C Virus RNA-Dependent RNA Polymerase NS5B
    Schult P; Nattermann M; Lauber C; Seitz S; Lohmann V
    J Virol; 2019 Oct; 93(19):. PubMed ID: 31315989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-nucleoside inhibitors binding to hepatitis C virus NS5B polymerase reveal a novel mechanism of inhibition.
    Biswal BK; Wang M; Cherney MM; Chan L; Yannopoulos CG; Bilimoria D; Bedard J; James MN
    J Mol Biol; 2006 Aug; 361(1):33-45. PubMed ID: 16828488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.